https://targeted-radiopharma-us.com/ 2026-03-16T14:03:13+00:00 https://targeted-radiopharma-us.com/sponsor/flywheel/ 2026-04-07T16:17:36+00:00 https://targeted-radiopharma-us.com/sponsor/thermo-fisher-scientific/ 2026-04-02T13:16:09+00:00 https://targeted-radiopharma-us.com/sponsor/medicines-discovery-catapult/ 2026-04-02T08:02:43+00:00 https://targeted-radiopharma-us.com/sponsor/almac/ 2026-04-02T08:01:14+00:00 https://targeted-radiopharma-us.com/sponsor/trasis-2/ 2026-03-31T13:48:58+00:00 https://targeted-radiopharma-us.com/sponsor/modular-devices/ 2026-03-30T09:43:15+00:00 https://targeted-radiopharma-us.com/sponsor/chelatec/ 2026-03-19T16:11:55+00:00 https://targeted-radiopharma-us.com/exhibitor/united-theranostics/ 2026-03-06T15:32:43+00:00 https://targeted-radiopharma-us.com/exhibitor/twostep-therapeutics/ 2026-03-06T15:32:36+00:00 https://targeted-radiopharma-us.com/exhibitor/trevarx-biomedical/ 2026-03-06T15:32:29+00:00 https://targeted-radiopharma-us.com/exhibitor/starget-pharma/ 2026-03-06T15:32:21+00:00 https://targeted-radiopharma-us.com/exhibitor/soricimed-biopharma/ 2026-03-06T15:32:14+00:00 https://targeted-radiopharma-us.com/exhibitor/solve-therapeutics/ 2026-03-06T15:32:07+00:00 https://targeted-radiopharma-us.com/exhibitor/rayzebio/ 2026-03-06T15:31:58+00:00 https://targeted-radiopharma-us.com/exhibitor/ratio-therapeutics/ 2026-03-06T15:31:47+00:00 https://targeted-radiopharma-us.com/exhibitor/radiopharm-theranostics/ 2026-03-06T15:31:41+00:00 https://targeted-radiopharma-us.com/exhibitor/radiomer-therapeutics/ 2026-03-06T15:31:33+00:00 https://targeted-radiopharma-us.com/exhibitor/mariana-oncology-3/ 2026-03-06T15:31:26+00:00 https://targeted-radiopharma-us.com/exhibitor/juniper-biosciences/ 2026-03-06T15:31:19+00:00 https://targeted-radiopharma-us.com/exhibitor/iron-fist-therapeutics/ 2026-03-06T15:31:11+00:00 https://targeted-radiopharma-us.com/exhibitor/hopo-therapeutics/ 2026-03-06T15:31:04+00:00 https://targeted-radiopharma-us.com/exhibitor/fusion-pharmaceuticals/ 2026-03-06T15:30:57+00:00 https://targeted-radiopharma-us.com/exhibitor/clarity-pharmaceuticals/ 2026-03-06T15:30:50+00:00 https://targeted-radiopharma-us.com/exhibitor/brookline-capital-markets/ 2026-03-06T15:30:39+00:00 https://targeted-radiopharma-us.com/exhibitor/blue-earth-therapeutics/ 2026-03-06T15:30:32+00:00 https://targeted-radiopharma-us.com/exhibitor/alpha-fusion/ 2026-03-06T15:30:21+00:00 https://targeted-radiopharma-us.com/exhibitor/affibody/ 2026-03-06T15:30:12+00:00 https://targeted-radiopharma-us.com/exhibitor/actinium-pharmaceuticals/ 2026-03-06T15:30:04+00:00 https://targeted-radiopharma-us.com/fundamentals-focus-day/ 2026-03-09T12:59:01+00:00 https://targeted-radiopharma-us.com/speaker/alex-mandel/ 2026-03-17T16:58:50+00:00 https://targeted-radiopharma-us.com/speaker/caitlyn-miller/ 2026-03-17T16:58:50+00:00 https://targeted-radiopharma-us.com/speaker/olga-issakova/ 2026-03-17T16:58:50+00:00 https://targeted-radiopharma-us.com/speaker/michel-afargan/ 2026-03-17T16:58:50+00:00 https://targeted-radiopharma-us.com/speaker/thomas-tulip/ 2026-03-17T16:58:51+00:00 https://targeted-radiopharma-us.com/speaker/michael-nickels/ 2026-03-17T16:58:51+00:00 https://targeted-radiopharma-us.com/speaker/yusuke-kohno/ 2026-03-17T16:58:50+00:00 https://targeted-radiopharma-us.com/speaker/chad-watkins/ 2026-03-17T16:58:51+00:00 https://targeted-radiopharma-us.com/speaker/caitlyn-harvey/ 2026-03-17T16:58:51+00:00 https://targeted-radiopharma-us.com/speaker/lauren-creeden/ 2026-03-17T16:58:51+00:00 https://targeted-radiopharma-us.com/speaker/john-babich/ 2026-03-17T16:58:51+00:00 https://targeted-radiopharma-us.com/speaker/jessica-guarnaschelli/ 2026-03-17T16:58:51+00:00 https://targeted-radiopharma-us.com/speaker/ben-hickey/ 2026-03-17T16:58:51+00:00 https://targeted-radiopharma-us.com/speaker/jean-cho/ 2026-03-17T16:58:51+00:00 https://targeted-radiopharma-us.com/speaker/mark-sellmyer/ 2026-03-17T16:58:51+00:00 https://targeted-radiopharma-us.com/speaker/isabella-pepe/ 2026-03-17T16:58:51+00:00 https://targeted-radiopharma-us.com/speaker/s-sakura-minami/ 2026-03-17T16:58:51+00:00 https://targeted-radiopharma-us.com/speaker/riccardo-canevari/ 2026-03-17T16:58:51+00:00 https://targeted-radiopharma-us.com/speaker/dhiren-patel/ 2026-03-17T16:58:51+00:00 https://targeted-radiopharma-us.com/speaker/ramzi-amri/ 2026-03-17T16:58:51+00:00 https://targeted-radiopharma-us.com/speaker/benjamin-titz/ 2026-03-17T16:58:51+00:00 https://targeted-radiopharma-us.com/speaker/david-ulmert/ 2026-03-17T16:58:51+00:00 https://targeted-radiopharma-us.com/speaker/waisi-eng/ 2026-03-17T16:58:51+00:00 https://targeted-radiopharma-us.com/speaker/marsela-braunstein/ 2026-03-17T16:58:51+00:00 https://targeted-radiopharma-us.com/speaker/brian-zeglis/ 2026-03-17T16:58:51+00:00 https://targeted-radiopharma-us.com/speaker/phillip-davis/ 2026-03-17T16:58:51+00:00 https://targeted-radiopharma-us.com/speaker/dan-stevens/ 2026-03-17T16:58:51+00:00 https://targeted-radiopharma-us.com/speaker/aruna-korde/ 2026-03-17T16:58:51+00:00 https://targeted-radiopharma-us.com/speaker/kemp-dolliver/ 2026-03-17T16:58:51+00:00 https://targeted-radiopharma-us.com/speaker/julian-rees/ 2026-03-17T16:58:51+00:00 https://targeted-radiopharma-us.com/speaker/alexander-schinagl/ 2026-03-17T16:58:51+00:00 https://targeted-radiopharma-us.com/speaker/liane-pinto/ 2026-03-17T16:58:51+00:00 https://targeted-radiopharma-us.com/speaker/jose-zayas/ 2026-03-17T16:58:51+00:00 https://targeted-radiopharma-us.com/speaker/gunilla-jacobson/ 2026-03-17T16:58:51+00:00 https://targeted-radiopharma-us.com/speaker/patrick-williams/ 2026-03-17T16:58:51+00:00 https://targeted-radiopharma-us.com/speaker/kirstin-zettlitz/ 2026-03-24T11:35:29+00:00 https://targeted-radiopharma-us.com/speaker/michael-groaning/ 2026-03-17T16:58:51+00:00 https://targeted-radiopharma-us.com/speaker/ben-pais/ 2026-03-17T16:58:51+00:00 https://targeted-radiopharma-us.com/speaker/scott-tagawa/ 2026-03-17T16:58:50+00:00 https://targeted-radiopharma-us.com/speaker/estelle-ricoux/ 2026-03-17T16:58:50+00:00 https://targeted-radiopharma-us.com/speaker/kostja-paschalidis/ 2026-03-17T16:58:50+00:00 https://targeted-radiopharma-us.com/speaker/molly-mcgaughan/ 2026-03-17T16:58:50+00:00 https://targeted-radiopharma-us.com/speaker/malini-iyer/ 2026-03-17T16:58:50+00:00 https://targeted-radiopharma-us.com/speaker/chris-pak/ 2026-03-17T16:58:51+00:00 https://targeted-radiopharma-us.com/speaker/melissa-rodnick/ 2026-03-17T16:58:50+00:00 https://targeted-radiopharma-us.com/speaker/kyle-hoffmann/ 2026-03-17T16:58:50+00:00 https://targeted-radiopharma-us.com/speaker/emily-lu/ 2026-03-17T16:58:50+00:00 https://targeted-radiopharma-us.com/speaker/cheryl-maley/ 2026-03-17T16:58:51+00:00 https://targeted-radiopharma-us.com/sponsor/tema-sinergie/ 2026-03-10T14:07:15+00:00 https://targeted-radiopharma-us.com/sponsor/omniab-inc/ 2026-03-06T15:40:08+00:00 https://targeted-radiopharma-us.com/sponsor/firm/ 2026-03-10T14:08:01+00:00 https://targeted-radiopharma-us.com/sponsor/psi-cro/ 2026-03-06T15:41:43+00:00 https://targeted-radiopharma-us.com/exhibitor/telix-therapeutics/ 2026-03-05T14:52:33+00:00 https://targeted-radiopharma-us.com/exhibitor/tailor-therapeutics/ 2026-03-05T14:52:14+00:00 https://targeted-radiopharma-us.com/exhibitor/starpharma/ 2026-03-05T14:52:08+00:00 https://targeted-radiopharma-us.com/exhibitor/pentixapharm/ 2026-03-05T14:52:01+00:00 https://targeted-radiopharma-us.com/exhibitor/oncoone/ 2026-03-05T14:51:53+00:00 https://targeted-radiopharma-us.com/exhibitor/nuclidium/ 2026-03-05T14:51:41+00:00 https://targeted-radiopharma-us.com/exhibitor/norroy-biosciences/ 2026-03-05T14:51:31+00:00 https://targeted-radiopharma-us.com/exhibitor/curadh/ 2026-03-05T14:51:24+00:00 https://targeted-radiopharma-us.com/exhibitor/bicycle-therapeutics/ 2026-03-05T14:51:16+00:00 https://targeted-radiopharma-us.com/exhibitor/abdera-therapeutics/ 2026-03-05T14:52:28+00:00 https://targeted-radiopharma-us.com/speaker/alessandro-mascioni/ 2026-03-17T16:58:50+00:00 https://targeted-radiopharma-us.com/exhibitor/eli-lilly-co/ 2025-07-08T15:19:21+00:00 https://targeted-radiopharma-us.com/exhibitor/convergent-therapeutics-inc/ 2025-07-08T15:15:17+00:00 https://targeted-radiopharma-us.com/exhibitor/bayer/ 2025-07-08T15:03:42+00:00 https://targeted-radiopharma-us.com/exhibitor/astrazeneca/ 2025-07-08T15:02:27+00:00 https://targeted-radiopharma-us.com/speaker/kawa-chiu/ 2026-03-17T16:58:51+00:00 https://targeted-radiopharma-us.com/speaker/munir-ghesani-2/ 2026-03-17T16:58:51+00:00 https://targeted-radiopharma-us.com/speaker/ammar-chaudhry/ 2026-03-17T16:58:51+00:00 https://targeted-radiopharma-us.com/speaker/ankur-nagaraja/ 2026-03-17T16:58:51+00:00 https://targeted-radiopharma-us.com/sponsor/biologic-pharma-solutions/ 2026-03-06T15:38:00+00:00 https://targeted-radiopharma-us.com/exhibitor/novartis/ 2025-03-20T11:24:12+00:00 https://targeted-radiopharma-us.com/exhibitor/mariana-oncology/ 2025-03-20T11:19:26+00:00 https://targeted-radiopharma-us.com/speaker/akshay-chellappa/ 2026-03-17T16:58:51+00:00 https://targeted-radiopharma-us.com/speaker/alison-armour/ 2026-03-17T16:58:51+00:00 https://targeted-radiopharma-us.com/speaker/guido-wuerth/ 2026-03-17T16:58:51+00:00 https://targeted-radiopharma-us.com/speaker/michael-evans/ 2026-03-17T16:58:51+00:00 https://targeted-radiopharma-us.com/speaker/erik-mittra/ 2026-03-17T16:58:51+00:00 https://targeted-radiopharma-us.com/speaker/dirk-pleimes/ 2026-03-17T16:58:51+00:00 https://targeted-radiopharma-us.com/speaker/david-mankoff/ 2026-03-17T16:58:51+00:00 https://targeted-radiopharma-us.com/speaker/chris-adams/ 2026-03-17T16:58:51+00:00 https://targeted-radiopharma-us.com/speaker/richard-messmann/ 2026-03-17T16:58:51+00:00 https://targeted-radiopharma-us.com/sponsor/perceptive/ 2026-04-07T16:20:40+00:00 https://targeted-radiopharma-us.com/sponsor/shine/ 2026-03-06T15:41:55+00:00 https://targeted-radiopharma-us.com/sponsor/pharmalogic/ 2026-04-07T16:22:01+00:00 https://targeted-radiopharma-us.com/pre-conference-day/ 2026-03-09T12:59:21+00:00 https://targeted-radiopharma-us.com/attendee-portal/ 2026-04-07T11:15:55+00:00 https://targeted-radiopharma-us.com/partner-portal/ 2026-04-07T11:21:22+00:00 https://targeted-radiopharma-us.com/speaker-portal/ 2026-04-07T13:15:26+00:00 https://targeted-radiopharma-us.com/about/content-hub/ 2026-03-09T11:00:15+00:00 https://targeted-radiopharma-us.com/media-partners/ 2025-06-24T14:55:30+00:00 https://targeted-radiopharma-us.com/why-partner/ 2026-03-09T13:00:07+00:00 https://targeted-radiopharma-us.com/about/poster-session/ 2026-03-09T12:58:36+00:00 https://targeted-radiopharma-us.com/about/hanson-wade/ 2025-03-13T11:14:07+00:00 https://targeted-radiopharma-us.com/about/about-event/ 2026-03-09T12:58:24+00:00 https://targeted-radiopharma-us.com/speakers/ 2026-03-09T12:59:27+00:00 https://targeted-radiopharma-us.com/about/thank-you-for-downloading/ 2025-06-18T10:48:36+00:00 https://targeted-radiopharma-us.com/about/thank-you-for-registering/ 2026-03-23T12:13:14+00:00 https://targeted-radiopharma-us.com/take-part/contact-us/ 2026-03-18T10:37:09+00:00 https://targeted-radiopharma-us.com/take-part/venue-accommodation/ 2026-03-23T12:20:25+00:00 https://targeted-radiopharma-us.com/take-part/register/ 2026-03-30T13:16:23+00:00 https://targeted-radiopharma-us.com/day-two/ 2026-03-09T12:58:49+00:00 https://targeted-radiopharma-us.com/day-one/ 2026-03-09T12:58:44+00:00 https://targeted-radiopharma-us.com/full-event-guide/ 2026-03-10T15:20:31+00:00 https://targeted-radiopharma-us.com/speakers-lse/ 2026-03-09T12:59:34+00:00 https://targeted-radiopharma-us.com/partnership-prospectus/ 2025-07-09T15:08:10+00:00 https://targeted-radiopharma-us.com/partners/ 2026-04-02T13:17:19+00:00 https://targeted-radiopharma-us.com/take-part/ 2025-06-18T10:50:28+00:00 https://targeted-radiopharma-us.com/about/ 2026-03-09T12:58:30+00:00 https://targeted-radiopharma-us.com/seminar/overcoming-risks-ethical-challenges-in-early-human-studies-using-phase-zero-one-trials-to-optimize-radiopharmaceutical-development/ 2026-03-17T16:58:49+00:00 https://targeted-radiopharma-us.com/seminar/workshop-e/ 2026-03-17T16:58:49+00:00 https://targeted-radiopharma-us.com/seminar/maximizing-clinical-impact-of-radioligand-therapy-through-combination-multimodal-strategies-with-parp-inhibitors-adcs/ 2026-03-17T16:58:49+00:00 https://targeted-radiopharma-us.com/seminar/workshop-b/ 2026-03-17T16:58:49+00:00 https://targeted-radiopharma-us.com/seminar/taking-emerging-alpha-emitters-from-discovery-through-development-to-scalable-supply-in-radioligand-therapy/ 2026-03-17T16:58:49+00:00 https://targeted-radiopharma-us.com/seminar/workshop-a/ 2026-03-17T16:58:49+00:00 https://targeted-radiopharma-us.com/seminar/advancing-safer-tumor-targeted-radiopharmaceuticals-through-molecular-design-safety-optimization/ 2026-03-17T16:58:49+00:00 https://targeted-radiopharma-us.com/seminar/workshop-d/ 2026-03-17T16:58:49+00:00 https://targeted-radiopharma-us.com/seminar/ensuring-quality-compliance-in-targeted-radiopharmaceuticals-to-navigate-cmc-regulatory-requirements-from-development-to-approval/ 2026-03-17T16:58:49+00:00 https://targeted-radiopharma-us.com/seminar/workshop-f/ 2026-03-17T16:58:49+00:00 https://targeted-radiopharma-us.com/seminar/check-in-light-breakfast/ 2026-03-17T16:58:49+00:00 https://targeted-radiopharma-us.com/seminar/lunch-networking/ 2026-03-17T16:58:49+00:00 https://targeted-radiopharma-us.com/seminar/solving-transport-operational-supply-chain-bottlenecks-to-enable-reliable-radioligand-therapy-delivery/ 2026-03-17T16:58:49+00:00 https://targeted-radiopharma-us.com/seminar/workshop-c/ 2026-03-17T16:58:49+00:00 https://targeted-radiopharma-us.com/seminar/end-of-pre-conference-workshop-day/ 2026-03-17T16:58:49+00:00 https://targeted-radiopharma-us.com/seminar/optimizing-your-drug-from-discovery-phase-key-targeting-moiety-engineering-for-optimal-biodistribution-half-life-whilst-minimizing-toxicity/ 2026-03-17T16:58:49+00:00 https://targeted-radiopharma-us.com/seminar/lowering-off%e2%80%91target-uptake-in-biologic-radiopharmaceuticals-through-protein-engineering/ 2026-03-17T16:58:49+00:00 https://targeted-radiopharma-us.com/seminar/optimizing-the-biodistribution-pharmacokinetics-of-abderas-rover-platform-to-maximize-tumor-uptake/ 2026-03-17T16:58:49+00:00 https://targeted-radiopharma-us.com/seminar/preclinical-evaluation-optimization-of-a-multi-specific-targeting-peptide-for-radioligand-therapy/ 2026-03-17T16:58:49+00:00 https://targeted-radiopharma-us.com/seminar/lunch-networking-2/ 2026-03-17T16:58:49+00:00 https://targeted-radiopharma-us.com/seminar/discovering-better-rlt-binders-targets-faster-screening-strategies-to-overcome-hit-id-bottlenecks/ 2026-03-17T16:58:49+00:00 https://targeted-radiopharma-us.com/seminar/navigating-next-generation-chelators-to-differentiate-advance-radiotherapeutics/ 2026-03-17T16:58:49+00:00 https://targeted-radiopharma-us.com/seminar/accelerating-radioligand-discovery-leveraging-in-silico-screening-ai-to-overcome-lead-finding-bottlenecks/ 2026-03-17T16:58:50+00:00 https://targeted-radiopharma-us.com/seminar/securing-isotope-supply-as-a-strategic-asset-mitigating-fragility-across-terbium-astatine-lead-other-emerging-radionuclides/ 2026-03-17T16:58:50+00:00 https://targeted-radiopharma-us.com/seminar/panel-discussion-investigating-various-isotope-half-lives-as-a-limiting-factor-in-radiotherapeutic-scalability-quality-control-patient-access/ 2026-03-17T16:58:50+00:00 https://targeted-radiopharma-us.com/seminar/session-reserved-for-pharmalogic-2/ 2026-03-17T16:58:50+00:00 https://targeted-radiopharma-us.com/seminar/securing-a-supply-of-isotopes-including-at-211-pb-212-tb-161-within-a-radioisotope-agnostic-portfolio/ 2026-03-17T16:58:50+00:00 https://targeted-radiopharma-us.com/seminar/lunch-networking-3/ 2026-03-17T16:58:50+00:00 https://targeted-radiopharma-us.com/seminar/managing-logistics-distribution-networks-with-centralized-vs-decentralized-manufacturing-to-streamline-trp-supply-chains-avoid-disruption-to-patient-care/ 2026-03-17T16:58:50+00:00 https://targeted-radiopharma-us.com/seminar/balancing-resilience-cost-supply-reliability-to-see-how-isotope-characteristics-drive-the-choice-between-centralized-vs-decentralized-manufacturing-models/ 2026-03-17T16:58:50+00:00 https://targeted-radiopharma-us.com/seminar/developing-a-radiopharmaceutical-clinical-operations-strategy/ 2026-03-17T16:58:50+00:00 https://targeted-radiopharma-us.com/seminar/morning-check-in-coffee/ 2026-03-17T16:58:50+00:00 https://targeted-radiopharma-us.com/seminar/program-directors-opening-remarks-2/ 2026-03-17T16:58:50+00:00 https://targeted-radiopharma-us.com/seminar/chairs-opening-remarks-3/ 2026-03-17T16:58:50+00:00 https://targeted-radiopharma-us.com/seminar/looking-at-competitive-outliers-strategies-for-true-pipeline-progression-from-early-promise-to-clinical-proof-of-concept-through-lessons-emerging-from-phase-ii-iii-rlt-studies/ 2026-03-17T16:58:50+00:00 https://targeted-radiopharma-us.com/seminar/scientific-advisory-board-fireside-chat-radiopharmaceuticals-in-2026-landscape-signals-inflection-points-what-comes-next/ 2026-03-17T16:58:50+00:00 https://targeted-radiopharma-us.com/seminar/session-reserved-for-psi-cro/ 2026-03-17T16:58:50+00:00 https://targeted-radiopharma-us.com/seminar/transforming-outcomes-in-advanced-sstr-positive-neuroendocrine-tumors-phase-3-progress-with-225ac-dotatate-targeted-alpha-therapy/ 2026-03-17T16:58:50+00:00 https://targeted-radiopharma-us.com/seminar/speed-networking-how-does-it-work/ 2026-03-17T16:58:50+00:00 https://targeted-radiopharma-us.com/seminar/speed-networking/ 2026-03-17T16:58:50+00:00 https://targeted-radiopharma-us.com/seminar/morning-break-networking-2/ 2026-03-17T16:58:50+00:00 https://targeted-radiopharma-us.com/seminar/mastermind-session-leveraging-patient-derived-xenograft-models-to-resolve-biodistribution-target-expression-radiosensitivity-relationships/ 2026-03-17T16:58:50+00:00 https://targeted-radiopharma-us.com/seminar/using-preclinical-models-to-better-understand-radiobiology-biodistribution-the-correlation-of-expression-radiosensitivity-activity/ 2026-03-17T16:58:50+00:00 https://targeted-radiopharma-us.com/seminar/how-subcellular-localization-of-alpha-particles-impacts-cytotoxicity-radiotherapeutic-efficacy/ 2026-03-17T16:58:50+00:00 https://targeted-radiopharma-us.com/seminar/a-review-of-the-radioconjugates-landscape/ 2026-03-17T16:58:50+00:00 https://targeted-radiopharma-us.com/seminar/lunch-networking-4/ 2026-03-17T16:58:50+00:00 https://targeted-radiopharma-us.com/seminar/developing-a-better-understanding-of-radiobiology-in-the-preclinic-to-address-tumor-resistance/ 2026-03-17T16:58:50+00:00 https://targeted-radiopharma-us.com/seminar/the-modern-biology-of-alpha-emitters-biologically-optimized-dna-damage/ 2026-03-17T16:58:50+00:00 https://targeted-radiopharma-us.com/seminar/modulating-tumor-microenvironment-mediated-resistance-mechanisms-to-enhance-radiotherapy-response-in-preclinical-models/ 2026-03-17T16:58:50+00:00 https://targeted-radiopharma-us.com/seminar/successfully-transitioning-from-diagnostic-imaging-agents-to-therapeutic-radioligands/ 2026-03-17T16:58:50+00:00 https://targeted-radiopharma-us.com/seminar/linking-imaging-of-brain-metastases-to-patient-treatment-change-of-management-for-novel-theranostic-strategies/ 2026-03-17T16:58:50+00:00 https://targeted-radiopharma-us.com/seminar/session-reserved-for-omniab/ 2026-03-17T16:58:50+00:00 https://targeted-radiopharma-us.com/seminar/from-imaging-to-therapeutic-impact-unlocking-the-clinical-potential-of-astatine-211-alpha-radioligand-therapy/ 2026-03-17T16:58:50+00:00 https://targeted-radiopharma-us.com/seminar/lunch-networking-5/ 2026-03-17T16:58:50+00:00 https://targeted-radiopharma-us.com/seminar/getting-first-in-human-right-the-first-time-designing-phase-0-early-safety-studies-that-de-risk-development/ 2026-03-17T16:58:50+00:00 https://targeted-radiopharma-us.com/seminar/integrating-imaging%e2%80%91derived-dosimetry-target-confirmation-to-optimize-therapeutic-first%e2%80%91in%e2%80%91human-study-design/ 2026-03-17T16:58:50+00:00 https://targeted-radiopharma-us.com/seminar/de-risking-first-in-human-psma-radioligand-therapy-by-translating-terbium-161-biology-dosimetry-safety-into-early-phase-dose-decisions/ 2026-03-17T16:58:50+00:00 https://targeted-radiopharma-us.com/seminar/session-choice/ 2026-03-17T16:58:50+00:00 https://targeted-radiopharma-us.com/seminar/powering-precision-oncology-with-late-stage-phase-2-phase-3-radiopharmaceutical-evidence/ 2026-03-17T16:58:50+00:00 https://targeted-radiopharma-us.com/seminar/the-roadmap-from-phase-i-to-phase-iii-standardizing-theranostic-protocols-for-clinical-trial-success/ 2026-03-17T16:58:50+00:00 https://targeted-radiopharma-us.com/seminar/introducing-the-safety-efficacy-of-conv01-alpha-for-the-treatment-of-men-with-advanced-prostate-cancer/ 2026-03-17T16:58:50+00:00 https://targeted-radiopharma-us.com/seminar/beyond-systemic-rlt-phase-2-evidence-of-local-alpha-therapy-to-prevent-peritoneal-recurrence/ 2026-03-17T16:58:50+00:00 https://targeted-radiopharma-us.com/seminar/powering-precision-oncology-at-scale-radiopharmaceutical-evidence-driving-approval-and-adoption/ 2026-03-17T16:58:50+00:00 https://targeted-radiopharma-us.com/seminar/chairs-closing-remarks-2/ 2026-03-17T16:58:50+00:00 https://targeted-radiopharma-us.com/seminar/end-of-scientific-program-day-one/ 2026-03-17T16:58:50+00:00 https://targeted-radiopharma-us.com/seminar/targeted-connections-drinks-reception/ 2026-03-17T16:58:50+00:00 https://targeted-radiopharma-us.com/seminar/linking-biodistribution-to-efficacy-in-radioligand-therapy-insights-limitations-from-preclinical-dosimetry/ 2026-03-17T16:58:50+00:00 https://targeted-radiopharma-us.com/seminar/preclinical-imaging-for-pk-evaluation-leveraging-pet-spect-to-optimize-biodistribution-dosimetry-efficacy/ 2026-03-17T16:58:50+00:00 https://targeted-radiopharma-us.com/seminar/mastermind-session-integrating-imaging-pk-data-for-smarter-dose-prediction-across-isotopes-targets/ 2026-03-17T16:58:50+00:00 https://targeted-radiopharma-us.com/seminar/investigating-the-preclinical-development-of-161tbtb-nym032-for-psma-targeting-radioligand-therapy/ 2026-03-17T16:58:50+00:00 https://targeted-radiopharma-us.com/seminar/lunch-networking-6/ 2026-03-17T16:58:50+00:00 https://targeted-radiopharma-us.com/seminar/one-one-four-combination-approaches-to-achieve-synergistic-effects-alongside-radioligand-therapy/ 2026-03-17T16:58:50+00:00 https://targeted-radiopharma-us.com/seminar/enhancing-radioligand-therapy-efficacy-through-rational-combination-with-ddr-inhibitors/ 2026-03-17T16:58:50+00:00 https://targeted-radiopharma-us.com/seminar/modulating-tumor-immunity-resistance-mechanisms-by-integrating-radioligand-therapy-with-immune-checkpoint-cellular-immunotherapies/ 2026-03-17T16:58:50+00:00 https://targeted-radiopharma-us.com/seminar/panel-discussion-shaping-the-future-of-combination-radioligand-therapy-preclinical-perspectives/ 2026-03-17T16:58:50+00:00 https://targeted-radiopharma-us.com/seminar/check-in-coffee/ 2026-03-17T16:58:50+00:00 https://targeted-radiopharma-us.com/seminar/program-directors-opening-remarks-3/ 2026-03-17T16:58:50+00:00 https://targeted-radiopharma-us.com/seminar/chairs-opening-remarks-4/ 2026-03-17T16:58:50+00:00 https://targeted-radiopharma-us.com/seminar/nuclear-medicine-or-unclear-medicine-navigating-funding-regulatory-bd-strategies-for-a-clear-pathway-from-discovery-to-the-clinic/ 2026-03-17T16:58:50+00:00 https://targeted-radiopharma-us.com/seminar/navigating-regulatory-complexities-in-radiopharmaceutical-development/ 2026-03-17T16:58:50+00:00 https://targeted-radiopharma-us.com/seminar/building-capacity-and-knowledge-for-effective-radioisotope-production-and-successful-radiopharmaceutical-programs/ 2026-03-17T16:58:50+00:00 https://targeted-radiopharma-us.com/seminar/overcoming-funding-barriers-for-radiopharmaceutical-innovation-through-looking-at-scientific-commercial-considerations/ 2026-03-17T16:58:50+00:00 https://targeted-radiopharma-us.com/seminar/panel-discussion-risk-versus-reward-investor-bd-perspectives-on-driving-growth-mitigating-risk-in-radiopharmaceutical-development/ 2026-03-17T16:58:50+00:00 https://targeted-radiopharma-us.com/seminar/morning-break-tech-showcase/ 2026-03-17T16:58:50+00:00 https://targeted-radiopharma-us.com/seminar/beyond-me-too-therapies-prioritizing-targets-beyond-psma-for-meaningful-rlt-indication-differentiation/ 2026-03-17T16:58:50+00:00 https://targeted-radiopharma-us.com/seminar/lead-optimization-trpv6-targeted-radioligand-therapy-sar-analysis-for-optimal-ligand-decision-making/ 2026-03-17T16:58:50+00:00 https://targeted-radiopharma-us.com/seminar/mastermind-session-what-is-the-ideal-radiopharmaceutical-target-overcoming-biological-translational-challenges-whilst-expanding-the-target-landscape/ 2026-03-17T16:58:50+00:00 https://targeted-radiopharma-us.com/seminar/overcoming-resistance-and-tumor-heterogeneity-in-small-cell-lung-cancer-by-targeting-dll3-to-unlock-new-therapeutic-opportunities/ 2026-03-17T16:58:50+00:00 https://targeted-radiopharma-us.com/seminar/lunch-networking-7/ 2026-03-17T16:58:50+00:00 https://targeted-radiopharma-us.com/seminar/mechanism-guided-design-of-radiopharmaceuticals-to-improve-target-affinity-address-tumor-resistance/ 2026-03-17T16:58:50+00:00 https://targeted-radiopharma-us.com/seminar/roundtable-discussion-exploring-future-opportunities-for-radioligand-therapy-moiety-engineering-to-optimize-therapeutic-activity/ 2026-03-17T16:58:50+00:00 https://targeted-radiopharma-us.com/seminar/overcoming-tumor-resistance-in-targeted-radiotherapy-through-high-affinity-tumor-specific-targeting-to-improve-therapeutic-efficacy/ 2026-03-17T16:58:50+00:00 https://targeted-radiopharma-us.com/seminar/overcoming-tumor-retention-challenges-in-radioligand-therapy-through-proximity-induced-covalent-binding/ 2026-03-17T16:58:50+00:00 https://targeted-radiopharma-us.com/seminar/managing-toxicity-therapeutic-index-in-radioligand-therapy-clinical-development-to-improve-patient-outcomes-whilst-retaining-efficacy/ 2026-03-17T16:58:50+00:00 https://targeted-radiopharma-us.com/seminar/virtual-presentation-identifying-biomarkers-to-overcome-patient-variability-in-177-lu-psma-617-therapy-to-guide-treatment-decisions-optimize-outcomes-in-mcrpc/ 2026-03-17T16:58:50+00:00 https://targeted-radiopharma-us.com/seminar/conducting-a-phase-zero-study-to-examine-hematologic-toxicities-understand-dose-limiting-effects-mechanistic-uncertainty-caused-by-bystander-irradiation/ 2026-03-17T16:58:50+00:00 https://targeted-radiopharma-us.com/seminar/introducing-first-human-data-from-her-2-targeting-agent-aby-271-affibody-molecule/ 2026-03-17T16:58:50+00:00 https://targeted-radiopharma-us.com/seminar/lunch-networking-8/ 2026-03-17T16:58:50+00:00 https://targeted-radiopharma-us.com/seminar/optimizing-rlt-dose-and-schedule-through-clinical-dosimetry-balancing-patient-safety-efficacy-resource-constraints/ 2026-03-17T16:58:50+00:00 https://targeted-radiopharma-us.com/seminar/optimizing-radiopharmaceutical-dosing-within-fda-guidance-strategies-to-maximize-efficacy-minimize-toxicity/ 2026-03-17T16:58:50+00:00 https://targeted-radiopharma-us.com/seminar/redefining-dose-optimization-for-rlt-by-moving-beyond-maximum-tolerated-dose-to-maximize-efficacy-safety-patient-benefit/ 2026-03-17T16:58:50+00:00 https://targeted-radiopharma-us.com/seminar/panel-discussion-personalized-vs-non-personalized-dosimetry-in-widespread-rlt-treatment-necessary-or-unsustainable/ 2026-03-17T16:58:50+00:00 https://targeted-radiopharma-us.com/seminar/roundtable-discussion-integrating-radiopharmacies-into-the-radiotherapy-manufacturing-ecosystem-to-expand-reach-reduce-strain-accelerate-patient-access/ 2026-03-17T16:58:50+00:00 https://targeted-radiopharma-us.com/seminar/designing-manufacturing-environments-that-enable-compliance-safety-sustainability-in-therapeutic-radiopharmaceutical-production/ 2026-03-17T16:58:50+00:00 https://targeted-radiopharma-us.com/seminar/harnessing-automation-digitization-in-targeted-radiotherapy-manufacturing-to-ensure-consistent-quality/ 2026-03-17T16:58:50+00:00 https://targeted-radiopharma-us.com/seminar/mastermind-session-strategic-design-of-radiopharmaceutical-facilities-for-overcoming-safety-contamination-operational-challenges-while-enabling-scalable-future-proof-production/ 2026-03-17T16:58:50+00:00 https://targeted-radiopharma-us.com/seminar/lunch-networking-9/ 2026-03-17T16:58:50+00:00 https://targeted-radiopharma-us.com/seminar/de-risking-radioligand-quality-early-defining-fit-for-purpose-cqas-control-strategies-from-preclinical-to-phase-iii/ 2026-03-17T16:58:50+00:00 https://targeted-radiopharma-us.com/seminar/measuring-potency-at-every-step-of-production-to-understand-shift-in-potency-appropriate-patient-dosage/ 2026-03-17T16:58:50+00:00 https://targeted-radiopharma-us.com/seminar/roundtable-discussion-reviewing-release-criteria-for-product-purity-to-understand-how-to-meet-them-ensure-high-purity/ 2026-03-17T16:58:50+00:00 https://targeted-radiopharma-us.com/seminar/changing-manufacturing-processes-to-improve-consistency-of-radiopharmaceutical-drug-products-improve-quality-readouts/ 2026-03-17T16:58:50+00:00 https://targeted-radiopharma-us.com/seminar/afternoon-break-networking-3/ 2026-03-17T16:58:50+00:00 https://targeted-radiopharma-us.com/seminar/scaling-radioligand-manufacturing-cmc-for-commercial-reality-to-navigate-the-road-from-phase-3-to-approval/ 2026-03-17T16:58:50+00:00 https://targeted-radiopharma-us.com/seminar/overcoming-isotope-scarcity-upstream-bottlenecks-for-next-generation-alpha-emitters/ 2026-03-17T16:58:50+00:00 https://targeted-radiopharma-us.com/seminar/building-human-capital-operational-readiness-to-deliver-radioligand-therapies-at-scale/ 2026-03-17T16:58:50+00:00 https://targeted-radiopharma-us.com/seminar/chairs-closing-remarks-3/ 2026-03-17T16:58:50+00:00 https://targeted-radiopharma-us.com/seminar/end-of-scientific-programme-day-two/ 2026-03-17T16:58:50+00:00 https://targeted-radiopharma-us.com/seminar/close-of-the-5th-trp-us-summit-goodbye-see-you-next-year/ 2026-03-17T16:58:50+00:00 https://targeted-radiopharma-us.com/seminar/chairs-opening-remarks-5/ 2026-03-17T16:58:50+00:00 https://targeted-radiopharma-us.com/seminar/transitioning-to-trps-introducing-the-roadmap-to-current-rlt-success-understanding-radioisotope-selection-fundamentals/ 2026-03-17T16:58:50+00:00 https://targeted-radiopharma-us.com/seminar/radiopharmaceutical-recap-landscape-updates-major-milestones-trends-from-recent-years/ 2026-03-17T16:58:50+00:00 https://targeted-radiopharma-us.com/seminar/selecting-the-right-radioisotope-maximizing-therapeutic-effect-while-minimizing-risk/ 2026-03-17T16:58:50+00:00 https://targeted-radiopharma-us.com/seminar/roundtable-discussion-designing-effective-trp-targets-by-exploring-emerging-clinical-candidates-lessons-from-other-targeted-therapies/ 2026-03-17T16:58:50+00:00 https://targeted-radiopharma-us.com/seminar/morning-break-networking-3/ 2026-03-17T16:58:50+00:00 https://targeted-radiopharma-us.com/seminar/beginning-to-build-your-rlt-toolbox-what-is-the-strategy-for-success/ 2026-03-17T16:58:50+00:00 https://targeted-radiopharma-us.com/seminar/harnessing-the-power-of-antibodies-peptides-small-molecules-to-optimize-rlt-performance/ 2026-03-17T16:58:50+00:00 https://targeted-radiopharma-us.com/seminar/roundtable-discussion-designing-the-ideal-radioligand-therapy-by-integrating-isotope-chelator-targeting-moiety-selection/ 2026-03-17T16:58:50+00:00 https://targeted-radiopharma-us.com/seminar/lunch-networking-10/ 2026-03-17T16:58:50+00:00 https://targeted-radiopharma-us.com/seminar/exploring-biodistribution-dosimetry-supply-chain-considerations-for-moving-to-clinical-trials/ 2026-03-17T16:58:50+00:00 https://targeted-radiopharma-us.com/seminar/exploring-radiopharmaceutical-cmc-processes-supply-chain-considerations-to-guide-development-2/ 2026-03-17T16:58:50+00:00 https://targeted-radiopharma-us.com/seminar/designing-a-radiopharmaceutical-clinical-trial-key-considerations-from-the-start-2/ 2026-03-17T16:58:50+00:00 https://targeted-radiopharma-us.com/seminar/fireside-chat-what-i-wish-i-knew-when-entering-radiopharma/ 2026-03-17T16:58:50+00:00 https://targeted-radiopharma-us.com/seminar/end-of-focus-fundamentals-day/ 2026-03-17T16:58:50+00:00